

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil mediated immunity (GO:0002446) | 5.63648035 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.43165917 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.43165917 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 5.43165917 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.43165917 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.43165917 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.43165917 |
| 8 | respiratory burst (GO:0045730) | 5.43023400 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.14649552 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.93050617 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.93050617 |
| 12 | defense response to fungus (GO:0050832) | 4.90879297 |
| 13 | cellular extravasation (GO:0045123) | 4.72831490 |
| 14 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.72470636 |
| 15 | negative regulation of phagocytosis (GO:0050765) | 4.68234165 |
| 16 | * response to fungus (GO:0009620) | 4.66783831 |
| 17 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.65977889 |
| 18 | leukocyte aggregation (GO:0070486) | 4.57037575 |
| 19 | detection of other organism (GO:0098543) | 4.48195641 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.40761822 |
| 21 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.39822295 |
| 22 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.36477870 |
| 23 | detection of bacterium (GO:0016045) | 4.36247520 |
| 24 | myeloid leukocyte mediated immunity (GO:0002444) | 4.32703685 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 4.32545086 |
| 26 | * response to peptidoglycan (GO:0032494) | 4.29825780 |
| 27 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.28195163 |
| 28 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.28195163 |
| 29 | neutrophil activation (GO:0042119) | 4.11989701 |
| 30 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.09157375 |
| 31 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.09157375 |
| 32 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.07914383 |
| 33 | positive regulation of B cell differentiation (GO:0045579) | 4.04846702 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.99941720 |
| 35 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.97516842 |
| 36 | detection of external biotic stimulus (GO:0098581) | 3.91929594 |
| 37 | leukocyte mediated cytotoxicity (GO:0001909) | 3.88614898 |
| 38 | negative regulation of granulocyte differentiation (GO:0030853) | 3.88596545 |
| 39 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.88104946 |
| 40 | granulocyte activation (GO:0036230) | 3.87492671 |
| 41 | immunoglobulin mediated immune response (GO:0016064) | 3.81731868 |
| 42 | leukotriene metabolic process (GO:0006691) | 3.80825608 |
| 43 | pinocytosis (GO:0006907) | 3.78429720 |
| 44 | mannose metabolic process (GO:0006013) | 3.76475058 |
| 45 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.76348545 |
| 46 | response to host immune response (GO:0052572) | 3.76348545 |
| 47 | detection of molecule of bacterial origin (GO:0032490) | 3.75491011 |
| 48 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.74398529 |
| 49 | positive regulation of antigen processing and presentation (GO:0002579) | 3.71458575 |
| 50 | regulation of mast cell degranulation (GO:0043304) | 3.70058814 |
| 51 | regulation of gamma-delta T cell activation (GO:0046643) | 3.69688804 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.66868267 |
| 53 | regulation of hypersensitivity (GO:0002883) | 3.65725023 |
| 54 | superoxide anion generation (GO:0042554) | 3.63400710 |
| 55 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.62475940 |
| 56 | macrophage differentiation (GO:0030225) | 3.62347362 |
| 57 | negative regulation of interleukin-12 production (GO:0032695) | 3.61047042 |
| 58 | reactive oxygen species biosynthetic process (GO:1903409) | 3.60686733 |
| 59 | detection of biotic stimulus (GO:0009595) | 3.55488929 |
| 60 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.53482613 |
| 61 | regulation of growth of symbiont in host (GO:0044126) | 3.53482613 |
| 62 | negative regulation of growth of symbiont in host (GO:0044130) | 3.53482613 |
| 63 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.53482613 |
| 64 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.51080655 |
| 65 | regulation of regulated secretory pathway (GO:1903305) | 3.48976303 |
| 66 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.47717083 |
| 67 | regulation of mast cell activation (GO:0033003) | 3.46627168 |
| 68 | positive regulation of leukocyte degranulation (GO:0043302) | 3.43846529 |
| 69 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.43564728 |
| 70 | glycosphingolipid catabolic process (GO:0046479) | 3.42901610 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.40600983 |
| 72 | microglial cell activation (GO:0001774) | 3.35561764 |
| 73 | regulation of leukocyte degranulation (GO:0043300) | 3.35394397 |
| 74 | * response to muramyl dipeptide (GO:0032495) | 3.33977154 |
| 75 | response to host (GO:0075136) | 3.32704799 |
| 76 | response to host defenses (GO:0052200) | 3.32704799 |
| 77 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.32704799 |
| 78 | disruption of cells of other organism (GO:0044364) | 3.31546241 |
| 79 | killing of cells of other organism (GO:0031640) | 3.31546241 |
| 80 | response to protozoan (GO:0001562) | 3.27867646 |
| 81 | regulation of B cell differentiation (GO:0045577) | 3.21963116 |
| 82 | ribosomal small subunit assembly (GO:0000028) | 3.21048075 |
| 83 | sequestering of metal ion (GO:0051238) | 3.19993666 |
| 84 | positive regulation of mast cell activation (GO:0033005) | 3.19715624 |
| 85 | positive regulation of interferon-alpha production (GO:0032727) | 3.18147290 |
| 86 | neutrophil chemotaxis (GO:0030593) | 3.18018359 |
| 87 | pentose-phosphate shunt (GO:0006098) | 3.15342299 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 3.12937285 |
| 89 | negative regulation of interleukin-6 production (GO:0032715) | 3.09910410 |
| 90 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.09412603 |
| 91 | adenosine receptor signaling pathway (GO:0001973) | 3.09346689 |
| 92 | positive thymic T cell selection (GO:0045059) | 3.08406237 |
| 93 | neutrophil migration (GO:1990266) | 3.08129638 |
| 94 | * regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.07097828 |
| 95 | glycolipid catabolic process (GO:0019377) | 3.06578806 |
| 96 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.06163756 |
| 97 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.05752946 |
| 98 | negative regulation of T cell mediated immunity (GO:0002710) | 3.05528971 |
| 99 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05451749 |
| 100 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.05186381 |
| 101 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.03827627 |
| 102 | B cell receptor signaling pathway (GO:0050853) | 3.02790127 |
| 103 | myeloid dendritic cell activation (GO:0001773) | 3.02277516 |
| 104 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.01245887 |
| 105 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.00327150 |
| 106 | leukotriene biosynthetic process (GO:0019370) | 2.99380133 |
| 107 | germinal center formation (GO:0002467) | 2.98807351 |
| 108 | regulation of interferon-alpha production (GO:0032647) | 2.98325298 |
| 109 | positive regulation of regulated secretory pathway (GO:1903307) | 2.98232910 |
| 110 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.98135721 |
| 111 | actin nucleation (GO:0045010) | 2.96879739 |
| 112 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.96525375 |
| 113 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96377382 |
| 114 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.94316524 |
| 115 | lipoxygenase pathway (GO:0019372) | 2.92823752 |
| 116 | mature B cell differentiation (GO:0002335) | 2.91741733 |
| 117 | viral transcription (GO:0019083) | 2.90909417 |
| 118 | regulation of superoxide anion generation (GO:0032928) | 2.89394128 |
| 119 | leukocyte degranulation (GO:0043299) | 2.89217507 |
| 120 | B cell mediated immunity (GO:0019724) | 2.88802966 |
| 121 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.88641069 |
| 122 | natural killer cell mediated immunity (GO:0002228) | 2.87542163 |
| 123 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.87542163 |
| 124 | positive regulation of mast cell degranulation (GO:0043306) | 2.87212077 |
| 125 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.87212077 |
| 126 | macrophage activation (GO:0042116) | 2.87123322 |
| 127 | leukocyte cell-cell adhesion (GO:0007159) | 2.85127422 |
| 128 | cell killing (GO:0001906) | 2.84723825 |
| 129 | * positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.84284909 |
| 130 | oligosaccharide catabolic process (GO:0009313) | 2.83322680 |
| 131 | adaptation of signaling pathway (GO:0023058) | 2.81435663 |
| 132 | cellular response to zinc ion (GO:0071294) | 2.81215089 |
| 133 | defense response to protozoan (GO:0042832) | 2.80348486 |
| 134 | regulation of phagocytosis (GO:0050764) | 2.79640290 |
| 135 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.79056301 |
| 136 | amino sugar catabolic process (GO:0046348) | 2.74917296 |
| 137 | myeloid leukocyte activation (GO:0002274) | 2.74798059 |
| 138 | NIK/NF-kappaB signaling (GO:0038061) | 2.73988151 |
| 139 | mature B cell differentiation involved in immune response (GO:0002313) | 2.70588642 |
| 140 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.66878466 |
| 141 | negative thymic T cell selection (GO:0045060) | 2.66168866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.95365282 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.47703530 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.20829533 |
| 4 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.98511042 |
| 5 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.86375298 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.71585171 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.66452509 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.63256225 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.42791995 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.08059506 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.03159871 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.01771967 |
| 13 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.85380372 |
| 14 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.77579320 |
| 15 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.77072861 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.72464172 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.69555524 |
| 18 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.68413594 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.67233010 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.61256476 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.61186848 |
| 22 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.49714818 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.44969247 |
| 24 | MYC_22102868_ChIP-Seq_BL_Human | 2.39303380 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.31228056 |
| 26 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.18164558 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15496345 |
| 28 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.12687556 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.05406747 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 2.04199293 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01722729 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.98788596 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 1.94864667 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.91290422 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.89408684 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.88058316 |
| 37 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86752669 |
| 38 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.81549392 |
| 39 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.80935772 |
| 40 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80198577 |
| 41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77203652 |
| 42 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.76782633 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.74018539 |
| 44 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.73824562 |
| 45 | MYB_26560356_Chip-Seq_TH1_Human | 1.72698557 |
| 46 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.65086927 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.60459399 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.60305432 |
| 49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.54840028 |
| 50 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.52724095 |
| 51 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51631015 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50404207 |
| 53 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49808795 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.48127665 |
| 55 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.47821220 |
| 56 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.43679032 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43363202 |
| 58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42332050 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42161372 |
| 60 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.40752508 |
| 61 | MAF_26560356_Chip-Seq_TH2_Human | 1.40120175 |
| 62 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.39805205 |
| 63 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.38664027 |
| 64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.38218427 |
| 65 | P68_20966046_ChIP-Seq_HELA_Human | 1.37086224 |
| 66 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35363548 |
| 67 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.34227132 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.33677503 |
| 69 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.32373479 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.31992090 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27845992 |
| 72 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.26504275 |
| 73 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.26183322 |
| 74 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.26147352 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.25198627 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24741773 |
| 77 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21252244 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21188217 |
| 79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18870706 |
| 80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18423026 |
| 81 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18233955 |
| 82 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17923859 |
| 83 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17824656 |
| 84 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14782698 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13702980 |
| 86 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13557381 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13124106 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12555906 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10555224 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10486102 |
| 91 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08833054 |
| 92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08598525 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08345798 |
| 94 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.08325094 |
| 95 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08131885 |
| 96 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07946812 |
| 97 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07916539 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06798798 |
| 99 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06359824 |
| 100 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03559788 |
| 101 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03225314 |
| 102 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01918613 |
| 103 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01101366 |
| 104 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00977204 |
| 105 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00795664 |
| 106 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00641402 |
| 107 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00588996 |
| 108 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.00078336 |
| 109 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.99622378 |
| 110 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97741035 |
| 111 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.96689139 |
| 112 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.91918961 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.91171359 |
| 114 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.90412756 |
| 115 | GATA3_26560356_Chip-Seq_TH2_Human | 0.85151890 |
| 116 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.81360670 |
| 117 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.79193805 |
| 118 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78655509 |
| 119 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.75521112 |
| 120 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.75376360 |
| 121 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.74748933 |
| 122 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.73679803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.44066908 |
| 2 | MP0003436_decreased_susceptibility_to | 3.68678669 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.64854364 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.57696056 |
| 5 | * MP0002419_abnormal_innate_immunity | 3.22286598 |
| 6 | MP0005174_abnormal_tail_pigmentation | 2.98319029 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.94722409 |
| 8 | MP0005464_abnormal_platelet_physiology | 2.80119072 |
| 9 | MP0009785_altered_susceptibility_to | 2.71845632 |
| 10 | MP0000569_abnormal_digit_pigmentation | 2.65738476 |
| 11 | * MP0005025_abnormal_response_to | 2.64705909 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.63229552 |
| 13 | MP0003183_abnormal_peptide_metabolism | 2.59816493 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.45886662 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 2.41954645 |
| 16 | MP0001800_abnormal_humoral_immune | 2.39512186 |
| 17 | * MP0001819_abnormal_immune_cell | 2.32463102 |
| 18 | * MP0002420_abnormal_adaptive_immunity | 2.32453725 |
| 19 | * MP0002723_abnormal_immune_serum | 2.27049842 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.23876285 |
| 21 | MP0000685_abnormal_immune_system | 2.21259047 |
| 22 | MP0005671_abnormal_response_to | 2.19755215 |
| 23 | MP0001790_abnormal_immune_system | 2.16645816 |
| 24 | MP0005387_immune_system_phenotype | 2.16645816 |
| 25 | MP0000465_gastrointestinal_hemorrhage | 2.15155430 |
| 26 | MP0003724_increased_susceptibility_to | 2.11579523 |
| 27 | MP0006082_CNS_inflammation | 2.06399902 |
| 28 | MP0002166_altered_tumor_susceptibility | 2.03963756 |
| 29 | MP0000015_abnormal_ear_pigmentation | 2.03947401 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.99649415 |
| 31 | MP0002405_respiratory_system_inflammati | 1.94967988 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.92604295 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.92118778 |
| 34 | MP0002398_abnormal_bone_marrow | 1.91607449 |
| 35 | MP0009278_abnormal_bone_marrow | 1.91344632 |
| 36 | MP0000716_abnormal_immune_system | 1.87139344 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.79351486 |
| 38 | MP0001851_eye_inflammation | 1.75478376 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.74014859 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.73918980 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.71403598 |
| 42 | MP0001873_stomach_inflammation | 1.70980461 |
| 43 | MP0009840_abnormal_foam_cell | 1.70642500 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.70434328 |
| 45 | MP0004510_myositis | 1.68715466 |
| 46 | MP0002722_abnormal_immune_system | 1.67278452 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.65388881 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.65388881 |
| 49 | MP0010307_abnormal_tumor_latency | 1.64637590 |
| 50 | MP0002429_abnormal_blood_cell | 1.60384589 |
| 51 | MP0002006_tumorigenesis | 1.59814559 |
| 52 | MP0000490_abnormal_crypts_of | 1.58551380 |
| 53 | MP0000343_altered_response_to | 1.57411255 |
| 54 | MP0003693_abnormal_embryo_hatching | 1.51041279 |
| 55 | MP0005451_abnormal_body_composition | 1.50727297 |
| 56 | MP0010155_abnormal_intestine_physiology | 1.50471204 |
| 57 | MP0001853_heart_inflammation | 1.44711626 |
| 58 | * MP0008469_abnormal_protein_level | 1.41365764 |
| 59 | MP0004947_skin_inflammation | 1.39378888 |
| 60 | MP0000858_altered_metastatic_potential | 1.28980997 |
| 61 | MP0003075_altered_response_to | 1.27207986 |
| 62 | MP0003763_abnormal_thymus_physiology | 1.26836884 |
| 63 | MP0003448_altered_tumor_morphology | 1.23319487 |
| 64 | MP0002132_abnormal_respiratory_system | 1.21891218 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 1.21691596 |
| 66 | MP0002095_abnormal_skin_pigmentation | 1.17887388 |
| 67 | MP0000703_abnormal_thymus_morphology | 1.15628202 |
| 68 | MP0001663_abnormal_digestive_system | 1.05635029 |
| 69 | MP0003690_abnormal_glial_cell | 1.04811887 |
| 70 | MP0005310_abnormal_salivary_gland | 1.03544166 |
| 71 | MP0000371_diluted_coat_color | 0.99112674 |
| 72 | MP0005076_abnormal_cell_differentiation | 0.98339203 |
| 73 | MP0002998_abnormal_bone_remodeling | 0.97850798 |
| 74 | MP0004883_abnormal_blood_vessel | 0.97297419 |
| 75 | MP0002933_joint_inflammation | 0.96885298 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 0.95236274 |
| 77 | MP0003566_abnormal_cell_adhesion | 0.93883649 |
| 78 | MP0003453_abnormal_keratinocyte_physiol | 0.91477513 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.91246524 |
| 80 | MP0008260_abnormal_autophagy | 0.88334522 |
| 81 | MP0003866_abnormal_defecation | 0.87937770 |
| 82 | MP0002928_abnormal_bile_duct | 0.85697587 |
| 83 | MP0000604_amyloidosis | 0.84025809 |
| 84 | MP0004185_abnormal_adipocyte_glucose | 0.83630913 |
| 85 | MP0003828_pulmonary_edema | 0.82614388 |
| 86 | MP0001986_abnormal_taste_sensitivity | 0.81513996 |
| 87 | MP0010094_abnormal_chromosome_stability | 0.80767870 |
| 88 | MP0002019_abnormal_tumor_incidence | 0.78088456 |
| 89 | MP0005390_skeleton_phenotype | 0.76505463 |
| 90 | MP0003279_aneurysm | 0.75684983 |
| 91 | MP0005166_decreased_susceptibility_to | 0.75393838 |
| 92 | MP0009763_increased_sensitivity_to | 0.74431829 |
| 93 | MP0009764_decreased_sensitivity_to | 0.73800297 |
| 94 | MP0008873_increased_physiological_sensi | 0.71633299 |
| 95 | MP0003111_abnormal_nucleus_morphology | 0.70850167 |
| 96 | MP0002277_abnormal_respiratory_mucosa | 0.70230007 |
| 97 | MP0005164_abnormal_response_to | 0.69692963 |
| 98 | MP0003077_abnormal_cell_cycle | 0.67690094 |
| 99 | MP0000249_abnormal_blood_vessel | 0.66718912 |
| 100 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65318819 |
| 101 | MP0000313_abnormal_cell_death | 0.64952885 |
| 102 | MP0004381_abnormal_hair_follicle | 0.64244700 |
| 103 | MP0005409_darkened_coat_color | 0.63699657 |
| 104 | MP0005257_abnormal_intraocular_pressure | 0.63526551 |
| 105 | MP0009765_abnormal_xenobiotic_induced | 0.62777927 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.60519455 |
| 107 | MP0008004_abnormal_stomach_pH | 0.59444018 |
| 108 | MP0003795_abnormal_bone_structure | 0.59417542 |
| 109 | MP0003091_abnormal_cell_migration | 0.57836190 |
| 110 | MP0005083_abnormal_biliary_tract | 0.56912414 |
| 111 | MP0001958_emphysema | 0.56421408 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.55143664 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.54869940 |
| 114 | MP0001915_intracranial_hemorrhage | 0.54712377 |
| 115 | MP0002971_abnormal_brown_adipose | 0.54695391 |
| 116 | MP0005647_abnormal_sex_gland | 0.54502205 |
| 117 | MP0008874_decreased_physiological_sensi | 0.54107197 |
| 118 | MP0009379_abnormal_foot_pigmentation | 0.50360885 |
| 119 | MP0008007_abnormal_cellular_replicative | 0.48590513 |
| 120 | MP0002075_abnormal_coat/hair_pigmentati | 0.46581678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.70242691 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.26048407 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.94826734 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.63008204 |
| 5 | Chronic obstructive pulmonary disease (HP:0006510) | 4.95501916 |
| 6 | Obstructive lung disease (HP:0006536) | 4.95501916 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 4.81654622 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.49963200 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.30733583 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 4.12978905 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.01162780 |
| 12 | Myositis (HP:0100614) | 3.99981496 |
| 13 | Gingivitis (HP:0000230) | 3.93465635 |
| 14 | * Recurrent skin infections (HP:0001581) | 3.80162845 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.67236828 |
| 16 | * Recurrent fungal infections (HP:0002841) | 3.63363577 |
| 17 | Increased cerebral lipofuscin (HP:0011813) | 3.59513324 |
| 18 | Thrombocytosis (HP:0001894) | 3.50537371 |
| 19 | Periodontitis (HP:0000704) | 3.44212305 |
| 20 | Abnormality of glycolipid metabolism (HP:0010969) | 3.40973721 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.40973721 |
| 22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.40973721 |
| 23 | Cellulitis (HP:0100658) | 3.30042781 |
| 24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.23128648 |
| 25 | Glomerulonephritis (HP:0000099) | 3.22323317 |
| 26 | Thoracic kyphosis (HP:0002942) | 3.15195792 |
| 27 | Loss of speech (HP:0002371) | 3.12369704 |
| 28 | Recurrent viral infections (HP:0004429) | 3.11450880 |
| 29 | * Meningitis (HP:0001287) | 3.10689553 |
| 30 | Stomatitis (HP:0010280) | 3.10214569 |
| 31 | Amyloidosis (HP:0011034) | 3.08307980 |
| 32 | IgM deficiency (HP:0002850) | 3.06920236 |
| 33 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.95084206 |
| 34 | * Chronic mucocutaneous candidiasis (HP:0002728) | 2.94567876 |
| 35 | * Recurrent cutaneous fungal infections (HP:0011370) | 2.94567876 |
| 36 | Petechiae (HP:0000967) | 2.94521450 |
| 37 | Orchitis (HP:0100796) | 2.90282003 |
| 38 | J-shaped sella turcica (HP:0002680) | 2.89099739 |
| 39 | Prolonged bleeding time (HP:0003010) | 2.88067385 |
| 40 | Purpura (HP:0000979) | 2.84666983 |
| 41 | Increased serum ferritin (HP:0003281) | 2.83345483 |
| 42 | Osteomyelitis (HP:0002754) | 2.81377487 |
| 43 | Abnormality of the prostate (HP:0008775) | 2.79550644 |
| 44 | Agnosia (HP:0010524) | 2.79417604 |
| 45 | Epistaxis (HP:0000421) | 2.76407210 |
| 46 | Reticulocytopenia (HP:0001896) | 2.76385903 |
| 47 | Abnormality of the thoracic spine (HP:0100711) | 2.72573179 |
| 48 | Chronic otitis media (HP:0000389) | 2.71130046 |
| 49 | Pustule (HP:0200039) | 2.71097712 |
| 50 | Mucopolysacchariduria (HP:0008155) | 2.68378086 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.68378086 |
| 52 | Leukocytosis (HP:0001974) | 2.67810110 |
| 53 | Urticaria (HP:0001025) | 2.66412485 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.65055777 |
| 55 | Disinhibition (HP:0000734) | 2.63783083 |
| 56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.61300313 |
| 57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.61300313 |
| 58 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.61300313 |
| 59 | Vasculitis (HP:0002633) | 2.59996160 |
| 60 | Upper motor neuron abnormality (HP:0002127) | 2.56539332 |
| 61 | Abnormal platelet function (HP:0011869) | 2.55846927 |
| 62 | Impaired platelet aggregation (HP:0003540) | 2.55846927 |
| 63 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.54162375 |
| 64 | Eosinophilia (HP:0001880) | 2.53375955 |
| 65 | Inflammation of the large intestine (HP:0002037) | 2.52983915 |
| 66 | Optic neuritis (HP:0100653) | 2.52174421 |
| 67 | Retrobulbar optic neuritis (HP:0100654) | 2.52174421 |
| 68 | Hypertensive crisis (HP:0100735) | 2.50184716 |
| 69 | Mutism (HP:0002300) | 2.49479951 |
| 70 | Gastrointestinal inflammation (HP:0004386) | 2.41299431 |
| 71 | Panhypogammaglobulinemia (HP:0003139) | 2.41286975 |
| 72 | Neuronal loss in central nervous system (HP:0002529) | 2.39595779 |
| 73 | Abnormality of iron homeostasis (HP:0011031) | 2.39246901 |
| 74 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.38979760 |
| 75 | Encephalitis (HP:0002383) | 2.37814373 |
| 76 | Spontaneous hematomas (HP:0007420) | 2.37235317 |
| 77 | Granulocytopenia (HP:0001913) | 2.36428231 |
| 78 | Chest pain (HP:0100749) | 2.33856296 |
| 79 | Prostate neoplasm (HP:0100787) | 2.32352724 |
| 80 | Menorrhagia (HP:0000132) | 2.32184132 |
| 81 | Axonal loss (HP:0003447) | 2.24623269 |
| 82 | Interstitial pulmonary disease (HP:0006530) | 2.24006616 |
| 83 | Colitis (HP:0002583) | 2.23965357 |
| 84 | Joint hemorrhage (HP:0005261) | 2.23253393 |
| 85 | Pulmonary infiltrates (HP:0002113) | 2.20781677 |
| 86 | Abnormality of the lumbar spine (HP:0100712) | 2.19819142 |
| 87 | Basal ganglia calcification (HP:0002135) | 2.19384436 |
| 88 | Arterial thrombosis (HP:0004420) | 2.19373723 |
| 89 | Recurrent pneumonia (HP:0006532) | 2.18009734 |
| 90 | Nasal polyposis (HP:0100582) | 2.14632976 |
| 91 | Gingival bleeding (HP:0000225) | 2.13331409 |
| 92 | Autoimmune thrombocytopenia (HP:0001973) | 2.12002890 |
| 93 | Increased IgE level (HP:0003212) | 2.08736411 |
| 94 | Agammaglobulinemia (HP:0004432) | 2.06771530 |
| 95 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.06623895 |
| 96 | Hepatosplenomegaly (HP:0001433) | 2.05591805 |
| 97 | * Hemoptysis (HP:0002105) | 2.01533738 |
| 98 | Reduced antithrombin III activity (HP:0001976) | 2.01524879 |
| 99 | Myocardial infarction (HP:0001658) | 2.01234776 |
| 100 | Hematochezia (HP:0002573) | 2.00611897 |
| 101 | Deformed sella turcica (HP:0002681) | 1.98392976 |
| 102 | Thickened calvaria (HP:0002684) | 1.97451395 |
| 103 | Personality changes (HP:0000751) | 1.95080179 |
| 104 | Abnormality of T cell physiology (HP:0011840) | 1.95025433 |
| 105 | Thin bony cortex (HP:0002753) | 1.94676668 |
| 106 | Clubbing of toes (HP:0100760) | 1.94523243 |
| 107 | Pathologic fracture (HP:0002756) | 1.94338692 |
| 108 | Episodic fever (HP:0001954) | 1.93688311 |
| 109 | Abnormal number of erythroid precursors (HP:0012131) | 1.91630839 |
| 110 | Pallor (HP:0000980) | 1.90726029 |
| 111 | Sepsis (HP:0100806) | 1.90393878 |
| 112 | Global brain atrophy (HP:0002283) | 1.90048851 |
| 113 | Nephritis (HP:0000123) | 1.89282259 |
| 114 | Albinism (HP:0001022) | 1.87878638 |
| 115 | Hemorrhage of the eye (HP:0011885) | 1.87650318 |
| 116 | Abnormality of the nasal mucosa (HP:0000433) | 1.87033086 |
| 117 | Fatigue (HP:0012378) | 1.86434494 |
| 118 | Abnormality of eosinophils (HP:0001879) | 1.86180655 |
| 119 | Progressive neurologic deterioration (HP:0002344) | 1.86088896 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85956384 |
| 121 | * Skin ulcer (HP:0200042) | 1.85823326 |
| 122 | Premature loss of primary teeth (HP:0006323) | 1.84651059 |
| 123 | Abnormality of complement system (HP:0005339) | 1.83667320 |
| 124 | Recurrent lower respiratory tract infections (HP:0002783) | 1.82557790 |
| 125 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.82240229 |
| 126 | Osteolytic defects of the hand bones (HP:0009699) | 1.82240229 |
| 127 | Ocular albinism (HP:0001107) | 1.80350091 |
| 128 | Restrictive lung disease (HP:0002091) | 1.78379314 |
| 129 | Polyneuropathy (HP:0001271) | 1.78256303 |
| 130 | Polygenic inheritance (HP:0010982) | 1.76989626 |
| 131 | Polycythemia (HP:0001901) | 1.76781285 |
| 132 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76224443 |
| 133 | Splenomegaly (HP:0001744) | 1.75700831 |
| 134 | Spondylolisthesis (HP:0003302) | 1.75086767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK4 | 4.19822765 |
| 2 | MAP4K1 | 3.44659130 |
| 3 | BLK | 3.21778469 |
| 4 | RIPK4 | 3.14389338 |
| 5 | FES | 2.90362547 |
| 6 | TAOK3 | 2.87892084 |
| 7 | IRAK3 | 2.59796567 |
| 8 | PRPF4B | 2.45380988 |
| 9 | TYK2 | 2.40820149 |
| 10 | KIT | 2.35317015 |
| 11 | CLK1 | 2.29575209 |
| 12 | BTK | 2.02313825 |
| 13 | CSF1R | 2.00220559 |
| 14 | PKN2 | 1.98139556 |
| 15 | TEC | 1.91491574 |
| 16 | TGFBR2 | 1.86188377 |
| 17 | TBK1 | 1.83030323 |
| 18 | ERN1 | 1.70637856 |
| 19 | MAP3K14 | 1.61902313 |
| 20 | ZAP70 | 1.59237277 |
| 21 | GRK6 | 1.59077675 |
| 22 | EEF2K | 1.57921899 |
| 23 | HCK | 1.53663494 |
| 24 | SYK | 1.53239392 |
| 25 | SIK2 | 1.43504541 |
| 26 | NME2 | 1.42594154 |
| 27 | TXK | 1.40481899 |
| 28 | MAP2K3 | 1.40234014 |
| 29 | CSK | 1.38357700 |
| 30 | EPHB1 | 1.38239353 |
| 31 | IKBKE | 1.35900495 |
| 32 | MAP3K3 | 1.34748129 |
| 33 | STK10 | 1.28785847 |
| 34 | TESK2 | 1.27604493 |
| 35 | SMG1 | 1.23264935 |
| 36 | TAOK1 | 1.21996397 |
| 37 | PIM2 | 1.20105048 |
| 38 | TRPM7 | 1.18511996 |
| 39 | SIK1 | 1.15461860 |
| 40 | LYN | 1.15048330 |
| 41 | TAOK2 | 1.14860812 |
| 42 | IRAK2 | 1.12819949 |
| 43 | LCK | 1.12780863 |
| 44 | MAP3K1 | 1.11585841 |
| 45 | PAK4 | 1.10766418 |
| 46 | IKBKB | 1.07493033 |
| 47 | EIF2AK3 | 1.06465472 |
| 48 | TRIB3 | 1.06264885 |
| 49 | JAK1 | 1.04414155 |
| 50 | PIM1 | 1.04320781 |
| 51 | CAMKK2 | 1.02544096 |
| 52 | JAK3 | 1.02246606 |
| 53 | NEK2 | 0.97367451 |
| 54 | PDPK1 | 0.96809551 |
| 55 | JAK2 | 0.96175855 |
| 56 | TLK1 | 0.95498564 |
| 57 | RPS6KC1 | 0.94981193 |
| 58 | RPS6KL1 | 0.94981193 |
| 59 | BMPR2 | 0.94212903 |
| 60 | RPS6KA6 | 0.93270829 |
| 61 | TTN | 0.92587578 |
| 62 | MAP3K11 | 0.91739732 |
| 63 | MAPK12 | 0.91235585 |
| 64 | MARK2 | 0.89906301 |
| 65 | FGR | 0.89129498 |
| 66 | CDC42BPA | 0.86233975 |
| 67 | LRRK2 | 0.84830891 |
| 68 | MAP3K13 | 0.84487520 |
| 69 | CAMK1D | 0.83365782 |
| 70 | MAPK4 | 0.83189206 |
| 71 | YES1 | 0.82929362 |
| 72 | PRKD2 | 0.82815950 |
| 73 | MST1R | 0.76371280 |
| 74 | RPS6KA2 | 0.75849357 |
| 75 | KSR2 | 0.74962226 |
| 76 | PTK6 | 0.73074051 |
| 77 | TNK2 | 0.72204301 |
| 78 | MAP3K6 | 0.71054403 |
| 79 | ITK | 0.70107224 |
| 80 | SCYL2 | 0.69300389 |
| 81 | CAMK1G | 0.69237617 |
| 82 | FLT3 | 0.66844819 |
| 83 | STK16 | 0.66097623 |
| 84 | MAPK7 | 0.63876508 |
| 85 | EIF2AK2 | 0.62850974 |
| 86 | ICK | 0.61087829 |
| 87 | IRAK1 | 0.60611570 |
| 88 | VRK1 | 0.59536166 |
| 89 | SIK3 | 0.59283053 |
| 90 | MAP3K8 | 0.59242632 |
| 91 | TESK1 | 0.59141674 |
| 92 | CDK6 | 0.57903829 |
| 93 | CDK4 | 0.56886009 |
| 94 | RPS6KA4 | 0.56635260 |
| 95 | MOS | 0.55514631 |
| 96 | STK4 | 0.55257797 |
| 97 | MATK | 0.54740294 |
| 98 | MKNK2 | 0.54199259 |
| 99 | ABL2 | 0.51938243 |
| 100 | MAPKAPK2 | 0.51708869 |
| 101 | MAPKAPK3 | 0.48585205 |
| 102 | GRK7 | 0.47841695 |
| 103 | KDR | 0.47809188 |
| 104 | MAP3K10 | 0.47237538 |
| 105 | MAPK11 | 0.46514931 |
| 106 | MKNK1 | 0.43166294 |
| 107 | CDC7 | 0.42731189 |
| 108 | HIPK2 | 0.42517510 |
| 109 | MAP3K7 | 0.42498740 |
| 110 | MAP2K6 | 0.41796693 |
| 111 | PRKCD | 0.41561267 |
| 112 | DAPK1 | 0.40306860 |
| 113 | MAP3K12 | 0.39917975 |
| 114 | PRKG2 | 0.39131208 |
| 115 | ABL1 | 0.39125054 |
| 116 | MARK3 | 0.37786356 |
| 117 | NEK9 | 0.37052923 |
| 118 | ATR | 0.37017281 |
| 119 | FYN | 0.36955282 |
| 120 | PRKCQ | 0.36879276 |
| 121 | BCKDK | 0.36688761 |
| 122 | CAMKK1 | 0.35914230 |
| 123 | MAPK15 | 0.35712426 |
| 124 | CHUK | 0.35217127 |
| 125 | WEE1 | 0.35100721 |
| 126 | ALK | 0.33762584 |
| 127 | PDK1 | 0.33196067 |
| 128 | CDK12 | 0.32923800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.77361375 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.30291313 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.76075815 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.74018508 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.71349695 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.58066930 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.14828803 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.11775086 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.07770310 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.01446651 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 1.98830967 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.98343545 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.89074110 |
| 14 | DNA replication_Homo sapiens_hsa03030 | 1.87664948 |
| 15 | * Tuberculosis_Homo sapiens_hsa05152 | 1.82365613 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.73027525 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.70650092 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.69324161 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.67666599 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.64591084 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.61356685 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.59210792 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.57761465 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54925917 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.54884077 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.49839724 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.49081059 |
| 28 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43738646 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43617033 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.40361780 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36965960 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.36003512 |
| 33 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.33842258 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.32045894 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31922231 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29955552 |
| 37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27143205 |
| 38 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25253945 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.21361689 |
| 40 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.20578625 |
| 41 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19565164 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.17115102 |
| 43 | Homologous recombination_Homo sapiens_hsa03440 | 1.15700745 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.14324355 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.12152632 |
| 46 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09932011 |
| 47 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.09343610 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06138646 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.99352968 |
| 50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96541023 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.94962842 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92921951 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89535806 |
| 54 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.88305344 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82868758 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81830723 |
| 57 | Base excision repair_Homo sapiens_hsa03410 | 0.80611639 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79885732 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77810605 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.76625979 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.74066737 |
| 62 | Mismatch repair_Homo sapiens_hsa03430 | 0.73777222 |
| 63 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73482785 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72045136 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70283322 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70124768 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.68391644 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67728338 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66933966 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65884293 |
| 71 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65387165 |
| 72 | Spliceosome_Homo sapiens_hsa03040 | 0.65344823 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65045841 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64265596 |
| 75 | Bladder cancer_Homo sapiens_hsa05219 | 0.62937339 |
| 76 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62838547 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58296192 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57800050 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.57307384 |
| 80 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54984642 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54878928 |
| 82 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53851084 |
| 83 | Allograft rejection_Homo sapiens_hsa05330 | 0.53428287 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53191016 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53107903 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52682511 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52040648 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51626586 |
| 89 | ABC transporters_Homo sapiens_hsa02010 | 0.51315371 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50828003 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49174458 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47224532 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46507191 |
| 94 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46486744 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45643813 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45465684 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45239620 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.44871796 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44589081 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44210378 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44030435 |
| 102 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43392113 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42858217 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.42730290 |
| 105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42418318 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.40974821 |
| 107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40187843 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39850743 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39726481 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38291008 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38193917 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37486494 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37433670 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36749517 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34108723 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33598124 |
| 117 | Endocytosis_Homo sapiens_hsa04144 | 0.32851344 |
| 118 | Cell cycle_Homo sapiens_hsa04110 | 0.32663455 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.31791346 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.30414240 |
| 121 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.29286168 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.27086799 |
| 123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.25330611 |

